# Tolerability and Pharmacokinetics of Hypidone Hydrochloride in Healthy Subjects

> **NCT04598607** · PHASE1 · COMPLETED · sponsor: **Zhejiang Huahai Pharmaceutical Co., Ltd.** · enrollment: 36 (actual)

## Conditions studied

- Major Depressive Disorder

## Interventions

- **DRUG:** Hypidone Hydrochloride tablets
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT04598607
- **Lead sponsor:** Zhejiang Huahai Pharmaceutical Co., Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2020-10-30
- **Primary completion:** 2021-01-11
- **Final completion:** 2021-01-15
- **Target enrollment:** 36 (ACTUAL)
- **Last updated:** 2021-08-25


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04598607

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04598607, "Tolerability and Pharmacokinetics of Hypidone Hydrochloride in Healthy Subjects". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT04598607. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*